Back to results
US 7,442,383 B2Granted
Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass
AssigneeProtexeon Limited
InventorsNicholas Peter Franks, Mervyn Maze
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods of controlling neurological deficits in patients who have undergone cardiopulmonary bypass (CPB) by administering xenon to said patients.
Claims14
A method of controlling one or more neurological deficits associated with cardiopulmonary bypass in a mammal, said method comprising administering to the mammal:
- (i) prior to the commencement of cardiopulmonary bypass a gaseous mixture comprising xenon, the xenon having a percent concentration by volume of between about 12.5% and 50%;
- and
- (ii) during cardiopulmonary bypass a gaseous mixture comprising xenon, the xenon having a percent concentration by volume of between about 12.5% and 50%.
Dependencies are inferred from the claim text.